Announced details
Market benchmarks for the stock market and benchmarks for financial products such as ETFs
TOPIX is indexed with the market capitalisation on 4 January 1968 set at 100
Relationship arising from Japan Exchange Group's announcement that our shares will be included among the constituents of TOPIX. Capital, personnel, and ordinary business relationships are Not disclosed.
Japan Exchange Group, which operates and publishes TOPIX. Other information, including location, representative, business activities, capital, and year established, is Not disclosed.
Expected to comprise 1,669 of approximately 3,700 listed companies (986 excluding 683 companies subject to transitional measures)
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
Japan Exchange Group
| Item | Details |
|---|---|
| Names of Products / Services Covered | Telomelysin Injection, Next-Generation Telomelysin |
| Counterparty | Japan Exchange Group |
| Counterparty overview | Japan Exchange Group, which operates and publishes TOPIX. Other information, including location, representative, business activities, capital, and year established, is Not disclosed. |
| Relationship with the Company | Relationship arising from Japan Exchange Group's announcement that our shares will be included among the constituents of TOPIX. Capital, personnel, and ordinary business relationships are Not disclosed. |
| Launch date | 30 October 2026 (scheduled; start of inclusion among the constituents of TOPIX) |
| Applicable area | Market benchmarks for the stock market and benchmarks for financial products such as ETFs |
| Location scale | Expected to comprise 1,669 of approximately 3,700 listed companies (986 excluding 683 companies subject to transitional measures) |
| Usage history | TOPIX is indexed with the market capitalisation on 4 January 1968 set at 100 |
| Source | Japan Exchange Group |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Japan Exchange Group announced that our shares will be newly included among the constituents of TOPIX. The Representative Director stated that the company recognises that its flagship products and corporate value have received significant recognition.